Glyoxalase I Glu111Ala Polymorphism in Patients with Breast Cancer

REFERENCES

• Miyata T., Fu M., Kurokawa K., van Ypersele de Strihou C., Thorpe S., Baynes J. W. Autoxidation products of both carbohydrates and lipids are increased in uremic plasma: is there oxidative stress in uremia?. Kidney Int 1998; 54: 1290–1295
   PubMed Web of Science ®Google Scholar
• Evans M. D., Dizdaroglu M., Cooke M. S. Oxidative DNA damage and disease: induction, repair, and significance. Mutat Res 2004; 567: 1–61
   PubMed Web of Science ®Google Scholar
• Kang D., Hamasaki N. Alterations of mitochondrial DNA in common diseases and disease states: aging, neurodegeneration, heart failure, diabetes, and cancer. Curr Med Chem 2005; 12: 429–441
   PubMed Web of Science ®Google Scholar
• Beisswenger P. J., Howell S. K., Nelson R. G., Mauer M., Szwergold B. S. α-oxoaldehyde metabolism and diabetic complications. Biochem Soc Trans 2003; 31: 1358–1363
   PubMed Web of Science ®Google Scholar
• Kalousová M., Zima T., Tesa V., Dusilová-Sulková S., Škrha J. Advanced glycoxidation end products in chronic diseases—clinical chemistry and genetic backround. Mutat Res 2005; 579: 37–46
   PubMed Web of Science ®Google Scholar
• Bierhaus A., Hofmann M. A., Ziegler R. A., Nawroth P. P. AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus I. The AGE concept. Cardiovasc Res 1998; 37: 586–600
   PubMed Web of Science ®Google Scholar
• Kislinger T., Fu C., Huber B., Qu W., Taguchi A., Yan S. D., Hofmann M., Yan S. F., Pischetsrieder M., Stern D., Schmidt A. M. N(epsilon)-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell-signaling pathway and modulate gene expression. J Biol Chem 1999; 274: 31740–31749
   PubMed Web of Science ®Google Scholar
• Cengiz K. Increased incidence of neoplasia in chronic renal failure (20 years experience). Int Urol Nephrol 2002; 33: 121–126
   PubMedGoogle Scholar
• Schmidt A. M., Yan S. D., Yan S. F., Stern D. M. The biology of the receptor for advanced glycation end products and its ligands. Mol Cell Res 2000; 1489: 99–111
   Google Scholar
• Thornalley P. J. Glyoxalase I—structure, function, and a critical role in the enzymatic defence against glycation. Biochem Soc Trans 2003; 31: 1343–1348
   PubMed Web of Science ®Google Scholar
• Thornalley P. J. The glyoxalase system: new developments towards functional characterization of a metabolic pathway fundamental to biological life. Biochem J 1990; 269: 1–11
   PubMed Web of Science ®Google Scholar
• Gale C. P., Grant P. J. The characterization and functional analysis of the human glyoxalase I gene using methods of bioinformatics. Gene 2004; 340: 251–260
   PubMed Web of Science ®Google Scholar
• Politi P., Minoretii P., Falcone C., Martinelli V., Emanuele E. Association analysis of the functional Ala111Glu polymorphism of the glyoxalase I gene in panic disorder. Neurosci Lett 2006; 396: 163–166
   PubMed Web of Science ®Google Scholar
• Gale C. P., Futers T. S., Summers L. K. Common polymorphisms in the glyoxalase-1 gene and their association with prothrombotic factors. Diab Vasc Dis Res 2004; 1: 34–39
   PubMedGoogle Scholar
• Munch G., Keis R., Wessels A., Riederer P., Bahner U., Heidland A., Niwa T., Lemke H. D., Schinzel R. Determination of advanced glycation end products in serum by fluorescence spectroscopy and competitive ELISA. Eur J Clin Chem Clin Biochem 1997; 35: 669–677
   PubMedGoogle Scholar
• Henle T., Deppisch R., Beck W., Hergesell O., Hansch G. M., Ritz E. Advanced glycated end-products (AGEs) during haemodialysis treatment: discrepant results with different methodologies reflecting the heterogenity of AGE compounds. Nephrol Dial Transplant 1999; 14: 1968–1975
   PubMed Web of Science ®Google Scholar
• Haldane J. B.S. An exact test for randomness of mating. J Genet 1954; 52: 631–635
   Web of Science ®Google Scholar
• McCann V. J., Davis R. E., Welbourn T. A., Constable J., Beale D. G. Glyoxalase phenotypes in patients with diabetes mellitus. Aust N Z J Med 1981; 11: 380–382
   PubMedGoogle Scholar
• Thornalley P. J., Hooper N. I., Jenning P. E., Florkowski C. M., Jones A. M., Lunec J., Barnett A. H. The human red blood cell glyoxalase system in diabetes mellitus. Diab Res Clin Pract 1989; 7: 115–120
   PubMed Web of Science ®Google Scholar
• Di Ilio C., Angelucci S., Pennelli A., Zezz A., Tenaglia R., Sacchetta P. Glyoxalase activities in tumor and nontumor human urogenital tissues. Cancer Lett 1995; 96: 189–193
   PubMed Web of Science ®Google Scholar
• Di Ilio C., Del Boccio G., Casaccia R., Aceto A., Di Giacom F., Federici G. Selenium level and gluthatione activities in normal and neoplastic human lung tissues. Carcinogenesis 1987; 8: 281–284
   PubMed Web of Science ®Google Scholar
• Antognelli C., Baldracchini F., Talesa V. N., Constantini E., Zucchi A., Mearini E. Overexpression of glyoxalase system enzymes in human kidney tumor. Cancer J 2006; 12: 222–228
   PubMed Web of Science ®Google Scholar
• Rangnathan S., Tew K. D. Analysis of glyoxalase I from normal and tumor tissue from human colon. Biochim Biophys Acta 1993; 1182: 311–316
   PubMed Web of Science ®Google Scholar
• Rulli A., Carli L., Romani R., Baroni T., Giovannini E., Rosi G., Talesa V. Expression of glyoxalase I and II in normal and breast cancer tissues. Breast Cancer Res Treat 2001; 66: 67–72
   PubMed Web of Science ®Google Scholar
• Okado A., Kawasaki Y., Hasuike Y., Takahashi M., Teshima T., Fujii J., Taniguchi N. Induction of apoptotic cell death by methylglyoxal and 3-deoxyglucosone in macrophage-derived cell lines. Biochem Biophys Res Commun 1996; 225: 219–224
   PubMed Web of Science ®Google Scholar
• Jones M. B., Krutzsch H., Shu H., Zhao Y., Liotta L. A., Kohn E. C., Petricoin E. F., 3rd. Proteomic analysis and identification of new biomarkers and therapeutic targets for invasive ovarian cancer. Proteomics 2002; 2: 76–84
   PubMed Web of Science ®Google Scholar
• Zhang D., Tai K. L., Wong L. L., Chiu L., Sethi S. K., Koay E. S.C. Proteomic study reveals that proteins involved in metabolic and detoxification pathway are highly expressed in Her-2/neu-positive breast cancer. Mol Cell Proteom 2005; 11: 1686–1696
   Google Scholar
• Kamiya D., Uchihata Y., Ichikawa E., Kato K., Umezawa K. Reversal of anticancer drug resistance by COTC based on intracellular glutathione and glyoxalase I. Bioorg Med Chem Lett 2005; 15: 1111–1114
   PubMed Web of Science ®Google Scholar
• Thornalley P. J. Protecting the genome: defence against nucleotide glycation and emerging role of glyoxalase I overexpression in multidrug resistance in cancer chemotherpy. Biochem Soc Trans 2003; 31: 1372–1377
   PubMed Web of Science ®Google Scholar
• Samadi A. A., Fullerton S. A., Tortorelis D. G., Johnson G. B., Davidson S. D., Choudhury M. S., Mallouh C., Tazaki H., Konno S. Glyoxalase I phenotype as a potential risk factor for prostate carcinoma. Urology 2001; 57: 183–187
   PubMed Web of Science ®Google Scholar
• Rulli A., Antognelli C., Prezzi E., Baldracchini F., Piva F., Giovanni E., Talesa V. A possible regulatory role of 17β-estradiol and tamoxifen on glyoxalase I and glyoxalase II genes expression in MCF7 and BT20 human breast cancer cells. Breast Cancer Res Treat 2006; 96: 187–196
   PubMed Web of Science ®Google Scholar
• Tesařová P., Kalousová M., Trnková B., Soukupová J., Argalašová S., Mestek O., Petruželka L., Zima T. Carbonyl and oxidative stress in patients with breast cancer is there a relation to the stage of the disease?. Neoplasma 2007; 54: 219–224
   PubMed Web of Science ®Google Scholar
• Tesařová P., Kalousová M., Jáchymová M., Mestek O., Petruželka L., Zima T. Receptor for advanced glycation end products (RAGE)—soluble form (sRAGE) and gene polymorphisms in patients with breast cancer. Cancer Invest 2007; 25: 720–725
   PubMed Web of Science ®Google Scholar
• Kobayashi S., Kubo H., Suzuki T., Ishizawa K., Yamada M., He M., Yamamoto Y., Yamamoto H., Sasano H., Sasaki H., Suzuki S. Endogenous secretory receptor for advanced glycation end products in non-small-cell lung carcinoma. Am J Respir Crit Care Med 2007; 175: 184–189
   PubMed Web of Science ®Google Scholar